Bioavailability, Antipsoriatic Efficacy and Tolerability of a New Light Cream with Mometasone Furoate 0.1%

Episode von Medizin - Open Access LMU - Teil 19/22 von Ludwig-Maximilians-Universität München · 1. Januar 2012

Mometasone furoate, a potent glucocorticoid (class III) with a favorable benefit/risk ratio, has emerged as a standard medication for the treatment of inflammatory skin disorders. The purpose of the investigation presented here was to determine the noninferiority of a topical mometasone formulation, a light cream (O/W 60/40 emulsion) with mometasone furoate 0.1% (water content of 33%) versus marketed comparators. Using the vasoconstrictor assay, a strong blanching effect of the new cream (called Mometasone cream) comparable to that of a mometasone comparator, a fatty cream with mometasone furoate 0.1%, could be demonstrated. Thus, the topical bioavailability of the active ingredient mometasone furoate (0.1%) was regarded to be similar for Mometasone cream and the mometasone comparator. Using the psoriasis plaque test, a strong antipsoriatic effect comparable to that of the mometasone comparator was found for Mometasone cream after 12 days of occlusive treatment. A nearly identical reduction in the mean infiltrate thickness and similar mean AUC values were noted with both formulations confirmed by clinical assessment data. The noninferiority of Mometasone cream to its active comparator with re-spect to the AUC of change to baseline in infiltrate thickness was demonstrated. Both medications were well tolerated. Overall, Mometasone cream and the mometasone comparator showed similar efficacy and tolerability. Mometasone cream, in addition to its high potency and good tolerability, provides the properties of a light cream, which might make this new medication particularly suitable for application on acutely inflamed and sensitive skin. Copyright (C) 2012 S. Karger AG, Basel

Weitere Episoden von „Medizin - Open Access LMU - Teil 19/22“

• Antimicrobial Peptides and Skin: A Paradigm of Translational Medicine 1. Januar 2012
• Appraisal of WHO guidelines in maternal health using the AGREE II assessment tool. 1. Januar 2012
• Associations between blood glucose and carotid intima-media thickness disappear after adjustment for shared risk factors: the KORA F4 study. 1. Januar 2012
• Aszites, Pfortaderthrombose und hepatische Enzephalopathie bei Leberzirrhose: Aktuelle Therapieempfehlungen 1. Januar 2012
• Block of death-receptor apoptosis protects mouse cytomegalovirus from macrophages and is a determinant of virulence in immunodeficient hosts. 1. Januar 2012
• Body fat free mass is associated with the serum metabolite profile in a population-based study. 1. Januar 2012
• Botulinum Toxin A for the Treatment of Keloids 1. Januar 2012
• Color in context: psychological context moderates the influence of red on approach- and avoidance-motivated behavior. 1. Januar 2012
• Comparison of Intravitreal Bevacizumab Upload Followed by a Dexamethasone Implant versus Dexamethasone Implant Monotherapy for Retinal Vein Occlusion with Macular Edema 1. Januar 2012
• Cultured subventricular zone progenitor cells transduced with neurogenin-2 become mature glutamatergic neurons and integrate into the dentate gyrus. 1. Januar 2012
• DRGs in Transfusion Medicine and Hemotherapy in Germany 1. Januar 2012
• Efficacy and Patient-Reported Outcomes of a New Mometasone Cream Treating Atopic Eczema 1. Januar 2012
• Evaluating Depressive Symptoms in Schizophrenia: A Psychometric Comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale 1. Januar 2012
• Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients. 1. Januar 2012
• Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue 1. Januar 2012

Alle Episoden von Medizin - Open Access LMU - Teil 19/22 · Mehr Bildung-Podcasts